Cargando…
Molecular Properties of Drugs Handled by Kidney OATs and Liver OATPs Revealed by Chemoinformatics and Machine Learning: Implications for Kidney and Liver Disease
In patients with liver or kidney disease, it is especially important to consider the routes of metabolism and elimination of small-molecule pharmaceuticals. Once in the blood, numerous drugs are taken up by the liver for metabolism and/or biliary elimination, or by the kidney for renal elimination....
Autores principales: | Nigam, Anisha K., Ojha, Anupam A., Li, Julia G., Shi, Da, Bhatnagar, Vibha, Nigam, Kabir B., Abagyan, Ruben, Nigam, Sanjay K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8538396/ https://www.ncbi.nlm.nih.gov/pubmed/34684013 http://dx.doi.org/10.3390/pharmaceutics13101720 |
Ejemplares similares
-
Coordinate regulation of systemic and kidney tryptophan metabolism by the drug transporters OAT1 and OAT3
por: Granados, Jeffry C., et al.
Publicado: (2021) -
Key Role for the Organic Anion Transporters, OAT1 and OAT3, in the in vivo Handling of Uremic Toxins and Solutes
por: Wu, Wei, et al.
Publicado: (2017) -
A key role for the transporter OAT1 in systemic lipid metabolism
por: Granados, Jeffry C., et al.
Publicado: (2021) -
Loss of the Kidney Urate Transporter, Urat1, Leads to Disrupted Redox Homeostasis in Mice
por: Jamshidi, Neema, et al.
Publicado: (2023) -
Organic Anion and Cation SLC22 “Drug” Transporter (Oat1, Oat3, and Oct1) Regulation during Development and Maturation of the Kidney Proximal Tubule
por: Gallegos, Thomas F., et al.
Publicado: (2012)